| Robert J Arias, | |
|
4025 Rawlins St, Cheyenne, WY 82001-1900 | |
| (307) 426-4797 | |
| (307) 426-4799 |
| Full Name | Robert J Arias |
|---|---|
| Gender | Male |
| Speciality | Social Worker - Clinical |
| Location | 4025 Rawlins St, Cheyenne, Wyoming |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306366109 | NPI | - | NPPES |
| LCSW-210 | Other | WY | LCSW |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | LCSW210 (Wyoming) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Robert J Arias, 4025 Rawlins St, Cheyenne, WY 82001-1900 Ph: (307) 426-4797 | Robert J Arias, 4025 Rawlins St, Cheyenne, WY 82001-1900 Ph: (307) 426-4797 |
News Archive
A new study by researchers at the University of Connecticut Health Center, USA, reports the crucial nature of the pathogen pattern recognition receptor (PRRs), especially the two RLRs, retinoic acid-inducible gene I (RIG-I) and melanoma differentiation-associated protein 5 (MDA5), in triggering host cell immune responses within the cell. The RLRs are viral RNA sensors.
W. L. Gore & Associates (Gore) today announced it has received European CE Mark approval for an expanded indication of the GORE® VIABIL® Biliary Endoprosthesis that allows removal of the device up to 12 months after implantation for the treatment of benign or malignant biliary strictures. The GORE® VIABIL® Biliary Endoprosthesis first received CE Mark approval in December 1999 and U.S. Food and Drug Administration (FDA) approval in January 2002 for the treatment of biliary strictures due to malignant neoplasms.
Opening up a new pathway to fight cancer, researchers at the University of Pennsylvania have found a way to target an enzyme that is crucial to tumor growth while also blocking the mechanism that has made past attempts to target that enzyme resistant to treatment.
Venous Health Systems, a developer of solutions for treating vascular insufficiency by enhancing blood circulation, today announced that it has received 510 clearance from the Food & Drug Administration to market the Vasculaire Compression System in the United States.
Thousands of studies take place every year in healthcare settings. A report published recently in the American Journal of Preventative Medicine describes how to do many of these studies more rapidly.
› Verified 7 days ago
Gregory Stelzner, MSW, LCSW-950 Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 2909 Bent Ave, Cheyenne, WY 82001 Phone: 307-772-1142 | |
Chelsea Hampton, MSW PCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 604 E 25th St, Cheyenne, WY 82001 Phone: 307-637-3953 | |
Nolan Marie Vitzthum, MSW, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 4025 Rawlins St, Cheyenne, WY 82001 Phone: 307-426-4797 | |
Corinne Lea Hogg, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 2360 E Pershing Blvd, Cheyenne, WY 82001 Phone: 307-757-8583 | |
Alyssa Nicole Bjorkquist, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1807 Capitol Ave Ste 109, Cheyenne, WY 82001 Phone: 307-256-6467 | |
Mr. William David Anderson, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2360 E Pershing Blvd, Cheyenne, WY 82001 Phone: 307-778-7550 Fax: 307-778-7599 | |
Richard A Esquibel, BSW, CSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 604 E 25th St, Cheyenne, WY 82001 Phone: 307-637-3953 Fax: 307-638-6805 |